
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $9.2M | $12.4M | $10.2M | $6.3M | $7.4M | |
Revenue Growth (YoY) | -27% | 34.87% | -17.17% | -38.28% | 17.26% | |
Cost of Revenues | $6.5M | $8.6M | $7.1M | $4.6M | $4.9M | |
Gross Profit | $2.7M | $3.8M | $3.1M | $1.7M | $2.5M | |
Gross Profit Margin | 29.53% | 30.49% | 30.67% | 27.02% | 33.32% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.3M | $3.2M | $3.6M | $2.5M | $3M | |
Other Inc / (Exp) | -$51K | -$10K | $77K | -$618K | $479K | |
Operating Expenses | $3.3M | $3.2M | $3.6M | $2.5M | $3M | |
Operating Income | -$616K | $567K | -$477K | -$769K | -$535K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$600K | $568K | -$313K | -$1.1M | $147K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$146K | $101K | -$20K | -$161K | $38K | |
Net Income to Company | -$454K | $467K | -$293K | -$978K | $109K | |
Minority Interest in Earnings | -$7K | -$24K | -$1K | $19K | -$3K | |
Net Income to Common Excl Extra Items | -$461K | $443K | -$294K | -$959K | $106K | |
Basic EPS (Cont. Ops) | -$0.12 | $0.11 | -$0.07 | -$0.22 | $0.02 | |
Diluted EPS (Cont. Ops) | -$0.12 | $0.11 | -$0.07 | -$0.22 | $0.02 | |
Weighted Average Basic Share | $4M | $4M | $4.1M | $4.4M | $4.4M | |
Weighted Average Diluted Share | $4M | $4.2M | $4.1M | $4.4M | $4.4M | |
EBITDA | $384K | $1.7M | $664K | -$11K | $74K | |
EBIT | -$616K | $567K | -$477K | -$769K | -$535K | |
Revenue (Reported) | $9.2M | $12.4M | $10.2M | $6.3M | $7.4M | |
Operating Income (Reported) | -$616K | $567K | -$477K | -$769K | -$535K | |
Operating Income (Adjusted) | -$616K | $567K | -$477K | -$769K | -$535K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.8M | $3M | $1.7M | $1.4M | $1.5M | |
Revenue Growth (YoY) | -36.89% | 62.77% | -43.65% | -16.22% | 4.72% | |
Cost of Revenues | $1.5M | $2.1M | $1.4M | $1.4M | $1.2M | |
Gross Profit | $387K | $889K | $263K | $26K | $305K | |
Gross Profit Margin | 20.94% | 29.56% | 15.52% | 1.83% | 20.51% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1M | $1.1M | $1.5M | $749K | $957K | |
Other Inc / (Exp) | $43K | -$5K | $39K | -$706K | $319K | |
Operating Expenses | $1M | $1.1M | $1.5M | $749K | $957K | |
Operating Income | -$659K | -$166K | -$1.2M | -$723K | -$652K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$615K | -$169K | -$1.1M | -$1.3M | -$277K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$66K | $201K | -$10K | -$154K | $38K | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$2K | $1K | -$1K | $1K | -- | |
Net Income to Common Excl Extra Items | -$551K | -$369K | -$1.1M | -$1.2M | -$315K | |
Basic EPS (Cont. Ops) | -$0.14 | -$0.09 | -$0.28 | -$0.27 | -$0.08 | |
Diluted EPS (Cont. Ops) | -$0.14 | -$0.09 | -$0.28 | -$0.27 | -$0.08 | |
Weighted Average Basic Share | $4M | $4M | $4.1M | $4.6M | $4.4M | |
Weighted Average Diluted Share | $4M | $4.1M | $4.1M | $4.6M | $4.4M | |
EBITDA | -$659K | -$166K | -$1.2M | -$723K | -$652K | |
EBIT | -$659K | -$166K | -$1.2M | -$723K | -$652K | |
Revenue (Reported) | $1.8M | $3M | $1.7M | $1.4M | $1.5M | |
Operating Income (Reported) | -$659K | -$166K | -$1.2M | -$723K | -$652K | |
Operating Income (Adjusted) | -$659K | -$166K | -$1.2M | -$723K | -$652K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $9.2M | $12.4M | $10.2M | $6.3M | $7.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $6.5M | $8.6M | $7.1M | $4.6M | $4.9M | |
Gross Profit | $2.7M | $3.8M | $3.1M | $1.7M | $2.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.3M | $3.2M | $3.6M | $2.5M | $3M | |
Other Inc / (Exp) | -- | -$9K | $79K | -$618K | $479K | |
Operating Expenses | $3.3M | $3.2M | $3.6M | $2.5M | $3M | |
Operating Income | -$617K | $568K | -$472K | -$769K | -$535K | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$601K | $570K | -$306K | -$1.1M | $147K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$146K | $101K | -$21K | -$161K | $38K | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$6K | -$23K | -$2K | $19K | -$3K | |
Net Income to Common Excl Extra Items | -$461K | $446K | -$287K | -$959K | $106K | |
Basic EPS (Cont. Ops) | -$0.12 | $0.11 | -$0.07 | -$0.22 | $0.01 | |
Diluted EPS (Cont. Ops) | -$0.12 | $0.11 | -$0.08 | -$0.22 | $0.01 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$617K | $568K | -$472K | -$769K | -$535K | |
EBIT | -$617K | $568K | -$472K | -$769K | -$535K | |
Revenue (Reported) | $9.2M | $12.4M | $10.2M | $6.3M | $7.4M | |
Operating Income (Reported) | -$617K | $568K | -$472K | -$769K | -$535K | |
Operating Income (Adjusted) | -$617K | $568K | -$472K | -$769K | -$535K |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $12.4M | $10.2M | $6.3M | $7.4M | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $8.6M | $7.1M | $4.6M | $4.9M | -- | |
Gross Profit | $3.8M | $3.1M | $1.7M | $2.5M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.2M | $3.6M | $2.5M | $3M | -- | |
Other Inc / (Exp) | -$9K | $79K | -$618K | $479K | -- | |
Operating Expenses | $3.2M | $3.6M | $2.5M | $3M | -- | |
Operating Income | $568K | -$472K | -$769K | -$535K | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $570K | -$306K | -$1.1M | $147K | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $101K | -$21K | -$161K | $38K | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$23K | -$2K | $19K | -$3K | -- | |
Net Income to Common Excl Extra Items | $446K | -$287K | -$959K | $106K | -- | |
Basic EPS (Cont. Ops) | $0.11 | -$0.07 | -$0.22 | $0.01 | -- | |
Diluted EPS (Cont. Ops) | $0.11 | -$0.08 | -$0.22 | $0.01 | -- | |
Weighted Average Basic Share | $16.1M | $16.3M | $17.4M | $17.7M | -- | |
Weighted Average Diluted Share | $16.7M | $16.7M | $17.4M | $17.7M | -- | |
EBITDA | $568K | -$472K | -$769K | -$535K | -- | |
EBIT | $568K | -$472K | -$769K | -$535K | -- | |
Revenue (Reported) | $12.4M | $10.2M | $6.3M | $7.4M | -- | |
Operating Income (Reported) | $568K | -$472K | -$769K | -$535K | -- | |
Operating Income (Adjusted) | $568K | -$472K | -$769K | -$535K | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $7.8M | $6M | $7M | $6.6M | $6M | |
Short Term Investments | -- | $1.1M | -- | -- | -- | |
Accounts Receivable, Net | $973K | $2.3M | $1.9M | $1.3M | $1M | |
Inventory | $2.2M | $2.4M | $1.4M | $1.6M | $1.1M | |
Prepaid Expenses | $492K | $594K | $357K | $166K | $343K | |
Other Current Assets | $21K | $26K | $49K | $60K | $87K | |
Total Current Assets | $11.5M | $12.3M | $10.7M | $9.6M | $8.6M | |
Property Plant And Equipment | $3.6M | $2.4M | $2.9M | $1.4M | $878K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $15.5M | $14.9M | $13.9M | $11.3M | $9.6M | |
Accounts Payable | $653K | $828K | $928K | $935K | $613K | |
Accrued Expenses | $1.9M | $2.1M | $1.7M | $1.5M | $918K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $821K | $933K | $573K | $588K | $623K | |
Other Current Liabilities | $336K | $384K | $310K | $244K | $323K | |
Total Current Liabilities | $4M | $5.2M | $4.1M | $3.8M | $3.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.7M | $5.6M | $5.7M | $4.7M | $3.3M | |
Common Stock | $40K | $40K | $41K | $44K | $44K | |
Other Common Equity Adj | $48K | -$303K | -$444K | -$501K | -$516K | |
Common Equity | $9.8M | $9.3M | $8.2M | $6.6M | $6.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $17K | -- | $12K | -$7K | -$2K | |
Total Equity | $9.8M | $9.3M | $8.2M | $6.6M | $6.3M | |
Total Liabilities and Equity | $15.5M | $14.9M | $13.9M | $11.3M | $9.6M | |
Cash and Short Terms | $7.8M | $7.1M | $7M | $6.6M | $6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $7.8M | $6M | $7M | $6.6M | $6M | |
Short Term Investments | -- | $1.1M | -- | -- | -- | |
Accounts Receivable, Net | $973K | $2.3M | $1.9M | $1.3M | $1M | |
Inventory | $2.2M | $2.4M | $1.4M | $1.6M | $1.1M | |
Prepaid Expenses | $492K | $594K | $357K | $166K | $343K | |
Other Current Assets | $21K | $26K | $49K | $60K | $87K | |
Total Current Assets | $11.5M | $12.3M | $10.7M | $9.6M | $8.6M | |
Property Plant And Equipment | $3.6M | $2.4M | $2.9M | $1.4M | $878K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $15.5M | $14.9M | $13.9M | $11.3M | $9.6M | |
Accounts Payable | $653K | $828K | $928K | $935K | $613K | |
Accrued Expenses | $1.9M | $2.1M | $1.7M | $1.5M | $918K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $821K | $933K | $573K | $588K | $623K | |
Other Current Liabilities | $336K | $384K | $310K | $244K | $323K | |
Total Current Liabilities | $4M | $5.2M | $4.1M | $3.8M | $3.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.7M | $5.6M | $5.7M | $4.7M | $3.3M | |
Common Stock | $40K | $40K | $41K | $44K | $44K | |
Other Common Equity Adj | $48K | -$303K | -$444K | -$501K | -$516K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $17K | -- | $12K | -$7K | -$2K | |
Total Equity | $9.8M | $9.3M | $8.2M | $6.6M | $6.3M | |
Total Liabilities and Equity | $15.5M | $14.9M | $13.9M | $11.3M | $9.6M | |
Cash and Short Terms | $7.8M | $7.1M | $7M | $6.6M | $6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$454K | $467K | -$293K | -$978K | $109K | |
Depreciation & Amoritzation | $1M | $1.1M | $1.1M | $758K | $609K | |
Stock-Based Compensation | $93K | $87K | $89K | $58K | $61K | |
Change in Accounts Receivable | $1M | -$1.4M | -$141K | $1.1M | $168K | |
Change in Inventories | -$301K | -$167K | $794K | -$272K | $356K | |
Cash From Operations | -$104K | -$164K | $809K | $415K | -$360K | |
Capital Expenditures | $88K | $134K | $92K | $118K | $101K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$78K | -$1.2M | $991K | -$102K | $232K | |
Dividends Paid (Ex Special Dividend) | -$981K | -$569K | -$1M | -$616K | -$492K | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$902K | -$549K | -$920K | -$557K | -$492K | |
Beginning Cash (CF) | $8.8M | $7.8M | $6M | $7M | $6.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$1.1M | -$1.9M | $880K | -$244K | -$620K | |
Ending Cash (CF) | $7.8M | $6M | $7M | $6.6M | $6M | |
Levered Free Cash Flow | -$192K | -$298K | $717K | $297K | -$461K |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.